October 29, 2020
The “Improving Quality of Care in AD” report, commissioned and funded by Sanofi Genzyme & Regeneron and completed by KPMG, debuts at the annual meeting of the EADV. Changes to FDA regulations implemented as part of the CARES Act limit access to hydroquinone. This year’s Virtual Vegas Cosmetic Surgery and Aesthetic Dermatology conference features more than 72 hours of content over four days. Pfizer’s abrocitinib receives priority review designation from FDA for AD.